IRF-1 Intervention in the Classical ROS-Dependent Release of NETs during LPS-Induced Acute Lung Injury in Mice
Previously, we demonstrated that neutrophil extracellular traps (NETs) play an essential role in lipopolysaccharide (LPS)-induced acute lung injury. However, the underlying mechanism is unclear. In this study, we showed that knockout of interferon regulatory factor 1 (IRF-1) in mice strongly attenuated the generation of NETs and reactive oxygen species (ROS) production in neutrophils from bronchoalveolar lavage fluid and alleviated LPS-induced lung injury and systemic inflammation. Our in vitro experiments demonstrated that LPS-stimulated platelets induce NET release through two distinct processes: an ROS-independent early/rapid NETosis and a later ROS-dependent classical NETosis. Notably, the classical ROS-dependent pathway plays a dominant role in the generation of NETs. Furthermore, we showed that IRF-1 knockout does not affect the formation of NETs in early/rapid NETosis, but significantly attenuates ROS production and the generation of NETs in classical NETosis, which determines the total levels of NETs released by LPS-stimulated platelets. In conclusion, IRF-1 deficiency plays a key role in moderating the excessive NETs formed via ROS in the classical pathway and retaining the protective role of the low-NET levels generated in early/rapid NETosis, which may serve as a novel target in acute lung injury/acute respiratory distress syndrome.
KEY WORDSacute lung injury interferon regulatory factor-1 neutrophil extracellular traps reactive oxygen species lipopolysaccharide
S.L. performed the experiments and drafted the manuscript; S.L., Y.Y., Y.L., Z.M., and H.L. analyzed the data; S.L. and X.S. interpreted the experimental results; L.Z. verified the pathological results; S.L., H.L., Q.L., and M.D. prepared the figures; P.P. conceived and designed the research; P.P. and L.Z. edited and revised the manuscript; P.P. approved the final version of manuscript. All authors read and approved the final manuscript.
This work was supported by the National Natural Science Foundation of China (nos. 81770080 and 81470266).
Compliance with Ethical Standards
Conflict of Interest
The authors declare no competing interests.
- 3.Bellani, G., J.G. Laffey, T. Pham, E. Fan, L. Brochard, A. Esteban, L. Gattinoni, F. Van Haren, A. Larsson, and D.F. Mcauley. 2016. Epidemiology, patterns of care, and mortality for patients with acute respiratory distress syndrome in intensive care units in 50 countries. JAMA 315 (8): 788–800.CrossRefGoogle Scholar
- 14.Pan, P.H., J. Cardinal, M.L. Li, C.P. Hu, and A. Tsung. 2013. Interferon regulatory factor-1 mediates the release of high mobility group box-1 in endotoxemia in mice. Chinese Medical Journal 126 (5): 918–924.Google Scholar
- 16.Lee, H.J., Y.K. Oh, M. Rhee, J.Y. Lim, J.Y. Hwang, Y.S. Park, Y. Kwon, K.H. Choi, I. Jo, S.I. Park, B. Gao, and W.H. Kim. 2007. The role of STAT1/IRF-1 on synergistic ROS production and loss of mitochondrial transmembrane potential during hepatic cell death induced by LPS/d-GalN. Journal of Molecular Biology 369 (4): 967–984.CrossRefGoogle Scholar
- 25.Clark, S.R., A.C. Ma, S.A. Tavener, B. McDonald, Z. Goodarzi, M.M. Kelly, K.D. Patel, S. Chakrabarti, E. McAvoy, G.D. Sinclair, E.M. Keys, E. Allen-Vercoe, R. DeVinney, C.J. Doig, F.H.Y. Green, and P. Kubes. 2007. Platelet TLR4 activates neutrophil extracellular traps to ensnare bacteria in septic blood. Nature Medicine 13 (4): 463–469.CrossRefGoogle Scholar
- 28.Maugeri, N., L. Campana, M. Gavina, C. Covino, M. De Metrio, C. Panciroli, L. Maiuri, et al. 2014. Activated platelets present high mobility group box 1 to neutrophils, inducing autophagy and promoting the extrusion of neutrophil extracellular traps. Journal of Thrombosis and Haemostasis 12 (12): 2074–2088.CrossRefGoogle Scholar
- 29.Merza, M., H. Hartman, M. Rahman, R. Hwaiz, E. Zhang, E. Renstrom, L. Luo, M. Morgelin, S. Regner, and H. Thorlacius. 2015. Neutrophil extracellular traps induce trypsin activation, inflammation, and tissue damage in mice with severe acute pancreatitis. Gastroenterology 149 (7): 1920–1931.e1928.CrossRefGoogle Scholar
- 30.Rochael, N.C., A.B. Guimaraes-Costa, M.T. Nascimento, T.S. DeSouza-Vieira, M.P. Oliveira, E. Souza LF Garcia, M.F. Oliveira, and E.M. Saraiva. 2015. Classical ROS-dependent and early/rapid ROS-independent release of neutrophil extracellular traps triggered by Leishmania parasites. Scientific Reports 5: 18302.CrossRefGoogle Scholar
- 32.Carestia, A., T. Kaufman, L. Rivadeneyra, V.I. Landoni, R.G. Pozner, S. Negrotto, L.P. D'Atri, R.M. Gomez, and M. Schattner. 2016. Mediators and molecular pathways involved in the regulation of neutrophil extracellular trap formation mediated by activated platelets. Journal of Leukocyte Biology 99 (1): 153–162.CrossRefGoogle Scholar
- 33.Tadie, J.M., H.B. Bae, S. Jiang, D.W. Park, C.P. Bell, H. Yang, J.F. Pittet, K. Tracey, V.J. Thannickal, and E. Abraham. 2013. HMGB1 promotes neutrophil extracellular trap formation through interactions with toll-like receptor 4. American Journal of Physiology Lung Cellular and Molecular Physiology 304 (5): L342–L349.CrossRefGoogle Scholar
- 36.Sreeramkumar, Vinatha, José M. Adrover, Ivan Ballesteros, Maria Isabel Cuartero, Jan Rossaint, Izaskun Bilbao, Maria Nácher, Christophe Pitaval, Irena Radovanovic, and Yoshinori Fukui. 2014. Neutrophils scan for activated platelets to initiate inflammation. Science 346 (6214): 1234–1238.CrossRefGoogle Scholar
- 40.Baas, T., J.K. Taubenberger, P.Y. Chong, P. Chui, and M.G. Katze. 2006. SARS-CoV virus-host interactions and comparative etiologies of acute respiratory distress syndrome as determined by transcriptional and cytokine profiling of formalin-fixed paraffin-embedded tissues. Journal of Interferon & Cytokine Research 26 (5): 309–317.CrossRefGoogle Scholar
- 42.Lood, C., L.P. Blanco, M.M. Purmalek, C. Carmona-Rivera, S.S. De Ravin, C.K. Smith, H.L. Malech, J.A. Ledbetter, K.B. Elkon, and M.J. Kaplan. 2016. Neutrophil extracellular traps enriched in oxidized mitochondrial DNA are interferogenic and contribute to lupus-like disease. Nature Medicine 22 (2): 146–153.CrossRefGoogle Scholar